Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection

A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxacin (400 mg) following a once-daily oral administration in 28 patients with respiratory tract infection disease. The maximum plasma concentration and the area under the plasma concentration–time curve...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Respir Dis
Päätekijät: Ito, Fumitaka, Ohno, Yasushi, Toyoshi, Sayaka, Kaito, Daizo, Koumei, Yanase, Endo, Junki, Kamamiya, Fumihiko, Mori, Hidenori, Mori, Masahiro, Morishita, Megumi, Funaguchi, Norihiko, Minatoguchi, Shinya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933663/
https://ncbi.nlm.nih.gov/pubmed/26660898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815620338
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia